Presentation is loading. Please wait.

Presentation is loading. Please wait.

Introduction Objective Experimental Results and Discussion

Similar presentations


Presentation on theme: "Introduction Objective Experimental Results and Discussion"— Presentation transcript:

1 Introduction Objective Experimental Results and Discussion
ENHANCEMENT OF SOLUBILITY AND DISSOLUTION RATE OF CURCUMIN BY EUDRAGIT EPO-BASED SOLID DISPERSIONS PREPARED BY HOT MELT EXTRUSION AND SPRAY DRYING TECHNOLOGY Avinash B. Gangurde, S.D. Javeer, J.N. Pawar, D. Jaiswar ,Purnima D. Amin Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, University under Section 3 of UGC Act- 1956, Elite Status & Centre of Excellence - Govt. of Maharashtra, TEQIP Phase II Funded, Matunga (E), Mumbai – India Introduction Curcumin (CUR) is a highly lipophilic drug molecule with a wide range of pharmacological activities. However, its clinical utility is limited due to its poor aqueous solubility and degradation at alkaline pH restricts its oral bioavailability (Anand P. et al., 2007, Yang KY et al., 2007). Therefore, there is need to increase the solubility of curcumin to promote it for oral drug delivery. Strategies to overcome these problems include conversion of CUR to free flowing micro particles, improving the solubility of curcumin in acidic pH and improving its stability in aqueous media (Paradkar A et al., 2005). Spray drying (SD) is a technique used for development of micro particulate solid dispersions (SDs) for improving the stability and solubility of compounds (Araujo et al., 2010). Hot melt extrusion (HME) is a process in which the drug is embedded in polymeric carrier at an elevated temperature and pressure conditions to prepare solid dispersed powder. (Breitenbach et al., 2002). Cationic polymer (Eudragit EPO) based SDs by using scalable spray drying and hot melt extrusion techniques are the appropriate option for solubility and dissolution rate enhancement of curcumin powder. Objective To study the influence of cationic polymer Eudragit EPO on solubility and dissolution rate of poorly water soluble drug curcumin. The work also involved studying the effect of method of preparation of SDs on the dissolution rate of curcumin Experimental SDs of CUR were prepared by varying drug loading 1:0.5, 1:1 and 1:2 ratio as composition shown in Table. Component CUR1 CUR2 CUR3 CUR4 CUR5 CUR6 Hot Melt Extrusion (HME) Spray Drying (SD) CUR 75 50 35 Eudragit EPO 17 42.5 60 22.5 47.5 62.5 Methocel 2.5 PEG 400 5 --- Acetone q.s. Hot Melt Extrusion Curcumin + Eudragit EPO +PEG 400 Characterizations of SDs- DSC,FTIR,PXRD and SEM study Enhanced Solubility and dissolution rate Spray Drying Results and Discussion Saturation solubility study Characterization DSC PXRD In vitro dissolution study A-Plain CUR B-CUR6 C-CUR3 The solubility and dissolution rate of CUR was found to be higher in dispersions with higher concentration of Eudragit polymer. FTIR SEM Contact angle measurement DSC and PXRD revealed that SD prepared by hot melt extrusion and spray drying techniques showed decrease in crystallinity of curcumin when increasing polymer concentration. FTIR study confirmed the stability of drug. SEM study showed uniform spherical shape of spray dried particles and flat broken needles of different sizes, with well-developed edges of hot melt extruded particles. Samples SDs t=0 s t=60 s Neat CUR 70±2.42 65±2.12 CUR1 25±1.23 19±1.11 CUR2 18±1.23 14±1.14 CUR3 14±1.19 12±1.15 CUR4 28±1.67 21±1.43 CUR5 20±1.23 15±1.18 CUR6 15±1.23 12±1.18 Conclusion Eudragit EPO showed a significant increase in solubility and in-vitro release performance of CUR by hot melt extrusion (solubility 3 to 115 µg/ml & dissolution 35 to 64% in 2 hrs.) and spray drying technology (solubility 4 to 125 µg/ml & 30 to 63 % in 2 hrs. The solubility and dissolution rate of CUR was increased by increasing polymer concentration . The conversion of crystalline form of drug in to amorphous form through the formation of solid dispersion, increased dispersibility of drug are the contributing factor for solubility and dissolution rate enhancement. References Anand P, Kunnumakkara AB. Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises, Mol Pharm. 4(6), (2007). Yang KY, Lin LC, Tseng TY, Wang SC, Tsai TH. Oral bioavailability of curcumin in rat and the herbal analysis from curcuma longa by LC-MS/MS J chromatogr B. 853(1-2):183-9 (2007). 1st European Conferences on Pharmaceutics, France , Remis 2015 Authors wish to acknowledge UGC for providing financial support during research work and attending conference.


Download ppt "Introduction Objective Experimental Results and Discussion"

Similar presentations


Ads by Google